Jack Staddon, M.D., Ph.D.

Professional Background

Dr. Staddon is a pediatric hematologist/oncologist engaged in clinical care across the breadth of pediatric hematology and oncology. He has a strong background in research as a graduate of the Medical Scientist Training Program (MD/PhD) at the University of Minnesota. He completed Pediatric Residency at Loma Linda University and Pediatric Hematology/Oncology fellowship at the University of Utah. He is board certified in Pediatric Hematology/Oncology and has worked in this specialty since 2014 in Michigan, Montana, and Kansas.

• Other, Biology, Southwestern Adventist College, Keene, Texas
• BS, Zoology, Andrews Univerity, Berrien Springs, Michigan
• MD/PhD, Microbiology, University of Minnesota, Minneapolis, Minnesota
• Internship, Pediatrics, Loma Linda University School of Medicine, Loma Linda, California
• Residency, Pediatrics, Loma Linda University School of Medicine, Loma Linda, California

Research

Overview

Dr. Staddon is a graduate of the Medical Scientist Training Program (MD/PhD) at the University of Minnesota where he studied lateral gene transfer in gram positive bacteria in the laboratory of Dr. Gary Dunny. During his pediatric hematology/oncology fellowship he studied mechanisms of asparaginase-induced thrombophilia in pediatric leukemia patients Andrew Weyrich. He performed clinical research as a member of the Children's Oncology Group (COG) during fellowship and at Bronson Methodist Hospital in Michigan. As he joins the University of Kansas-Wichita, he sees great potential for continued clinical research through cooperative group trials such as COG.